National Cancer Institute Names Mayer Interim Director of Cancer Survivorship

Frances Hill Fox Distinguished Professor Deborah K. Mayer, PhD, RN, AOCN, FAAN, has been appointed interim director of the National Cancer Institute’s Office of Cancer Survivorship. She will maintain her appointments and responsibilities at UNC, which includes overseeing a clinical practice working with breast cancer survivors.

A nationally recognized leader in cancer survivorship, Mayer is an advanced practice oncology nurse with more than 40 years of experience in cancer nursing, education and research. She is a highly sought after lecturer on issues related to oncology and oncology nursing and has published more 150 articles and book chapters. In addition to her role on faculty at the School of Nursing, Mayer serves as director of cancer survivorship at the UNC Lineberger Comprehensive Cancer Center.

“We are pleased that Dr. Mayer has graciously agreed to serve as interim director of NCI’s Office of Cancer Survivorship. Her expertise will provide strong leadership for a critical component of NCI’s research mission and portfolio,” said Norman E. Sharpless, MD, director of the National Cancer Institute.

Mayer is past president of the Oncology Nursing Society (ONS) and a former member of the National Cancer Institute’s National Cancer Advisory Board and the Board of Scientific Advisors. She is the immediate past president of the American Society of Clinical Oncology Survivorship Committee. The ONS presented Mayer with its Lifetime Achievement Award in 2015, and in 2016, Mayer was appointed as the only nurse to the National Cancer Moonshot Initiative’s Blue Ribbon Panel.

Mayer will maintain her appointments and responsibilities at UNC, which includes overseeing a clinical practice working with breast cancer survivors.

“This is a wonderful privilege and opportunity to work with some of our brightest minds to better understand and address the needs of cancer survivors,” said Mayer. “While we already have made great strides in enhancing the lives of cancer survivors, there is much more we can do, and it is imperative we do more to help the growing population of cancer survivors.